High Cholesterol Medicine

As per available reports about 100 journals, 162 conferences, 30 workshops are presently dedicated exclusively to High Cholesterol Medicine and about 366282 articles are being published on the current trends in High Cholesterol Medicine. In terms of research annually; USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to High Cholesterol Medicine are being carried out. As reported in “Effect of Vildagliptin on Atherosclerosis Progression in High Cholesterol–Fed Male Rabbits” article by Hadi NR, et al. Atherosclerosis is a multifactorial, multistep disease that involves chronic inflammatory at every stage, from initiation to progression and, eventually, plaque rupture. Cardiovascular disease (CVD) is the principal cause of death and disability in developed countries and is increasing rapidly in the developing world. Endothelial dysfunction is the early step that allows dissemination of lipids and inflammatory cells into the endothelial and sub-endothelial spaces. Secretion of cytokines and growth factors promote SMC proliferation, accumulation of collagen matrix, monocytes infiltration, and other white blood cells, forming an atheroma.

The Journal of Clinical & Experimental Cardiology is an academic journal – hosted by OMICS International – a pioneer in open access publishing – and is listed among the top 10 journals in High Cholesterol Medicine. Each year research scientists have noticed a rise in the number of congresses being held in this field. The Journal of Clinical & Experimental Cardiology provides a unique platform to researchers and scientist to explore the advanced and latest research developments in the field of High Cholesterol Medicine and Cardiology, thus bridging the gap between researchers and young scientists.

OMICS International – a pioneer in organizing international conferences. The Journal of Clinical & Experimental Cardiology is associated with our conference "5th International Conference on Clinical & Experimental Cardiology” during April 27-29, 2015 Philadelphia, USA with a theme “Blooming landscapes in cardio research”. The major sessions include Heart Diseases, Congenital Heart Diseases, Cardiac Therapeutic Agents, Biophysics and Systems Biology, Interventional Cardiology, Cancer and Heart, Current Research in Cardiology, Cardiac Surgery and many others.